Hims & Hers (NYSE: HIMS) has been on a wild journey over the past year as GLP-1s drive both big gains and big losses for the ...

The Dow Jones Industrial Average lost 696.75 points, or 1.63%, to close at 41,938.45. The S&P 500 slid 1.54% to 5,827.04, ...

When it comes to the efficacy of a hair loss treatment, there’s nothing more telling than a before and after photo.

Citi downgraded Hims & Hers to Sell from Neutral with a price target of $25, up from $24. The firm thinks the market is overvaluing the ...

Citi downgraded Hims & Hers to Sell from Neutral with a $25 price target Stay Ahead of the Market:Discover outperforming stocks and invest ...

Forward, a tech-enabled, subscription-based primary care company, said it was shutting down 12 months after raising $100 million. Analysts predict it will be one of many companies to meet the same ...

Hims & Hers reported impressive third-quarter results in November, with earnings of 32 cents per share, far exceeding analyst ...

Hims offers convenient and affordable access to treatments and products tailored for men's health needs. But how much does it ...

What initially stands out to me about Hims & Hers is the company's distinct branding and feel of luxury, which is evident on ...

Two startups team up to help brands target TV viewers based on what and where they buy. And TikTok remains in will-they-won’t ...

Hims has become a leader in the weight loss treatment industry by offering access to men’s health solutions that are both ...

Hims & Hers Health Inc (HIMS) stock saw a modest uptick, ending the day at $27.67 which represents a slight increase of $0.77 or 2.86% from the prior close of $26.9. The stock opened at $27.68 and ...